|
TRIP12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.635200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.215700E-02 |
| Normal-vs-Stage2 |
1.891850E-02 |
| Normal-vs-Stage3 |
2.015600E-03 |
| Normal-vs-Stage4 |
4.718200E-03 |
| Stage1-vs-Stage2 |
4.054200E-01 |
| Stage1-vs-Stage3 |
1.626370E-01 |
| Stage1-vs-Stage4 |
2.665600E-01 |
| Stage2-vs-Stage3 |
9.259600E-01 |
| Stage2-vs-Stage4 |
8.453200E-01 |
| Stage3-vs-Stage4 |
8.833200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.344220E-02 |
| Normal-vs-AfricanAmerican |
7.643200E-01 |
| Normal-vs-Asian |
1.143630E-02 |
| Caucasian-vs-AfricanAmerican |
1.520020E-01 |
| Caucasian-vs-Asian |
6.012800E-01 |
| AfricanAmerican-vs-Asian |
8.354300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.755600E-03 |
| Normal-vs-Female |
1.751530E-02 |
| Male-vs-Female |
3.691600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.047420E-01 |
| Normal-vs-Age(41-60Yrs) |
1.801450E-03 |
| Normal-vs-Age(61-80Yrs) |
9.103000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.384850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.163600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.254200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.648200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.817000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.738400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.954000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.717200E-01 |
| Classical-VS-Follicular |
3.443900E-03 |
| Classical-VS-Other |
6.481800E-02 |
| Classical-VS-Normal |
9.206000E-02 |
| Tall-VS-Follicular |
4.634800E-01 |
| Tall-VS-Other |
1.702000E-01 |
| Tall-VS-Normal |
2.676400E-02 |
| Follicular-VS-Other |
4.368600E-01 |
| Follicular-VS-Normal |
8.155300E-04 |
| Other-VS-Normal |
9.800400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.337800E-03 |
| Normal-vs-N1 |
1.317950E-03 |
| N0-vs-N1 |
3.077000E-01 |
|
|
